KIFAP3 Monoclonal antibody

KIFAP3 Monoclonal Antibody for WB, IHC, ELISA
Cat No. 60266-1-Ig
Clone No.7C9F2

Host / Isotype

Mouse / IgG2a

Reactivity

human, mouse, rat

Applications

WB, IHC, ELISA

KAP 3, KAP3, KIF3AP, KIFAP3, kinesin associated protein 3, SMAP, Smg GDS, Smg GDS associated protein

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inhuman testis tissue
Positive IHC detected inhuman testis tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

60266-1-Ig targets KIFAP3 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Host / Isotype Mouse / IgG2a
Class Monoclonal
Type Antibody
Immunogen KIFAP3 fusion protein Ag20809 Predict reactive species
Full Name kinesin-associated protein 3
Calculated Molecular Weight 792 aa, 91 kDa
Observed Molecular Weight 91-100 kDa
GenBank Accession NumberBC028679
Gene Symbol KIFAP3
Gene ID (NCBI) 22920
RRIDAB_2881387
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDQ92845
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

KIFAP3, also known as KIF3AP or KAP3, is a novel KIF3A/3B-associated protein. It binds to the tail domain of KIF3A/3B and may play a role in regulating the binding of KIF3A/3B to cargoes. Recently it has been reported that mutation within the KIFAP3 gene is associated with decreased KIFAP3 expression and increased survival in sporadic ALS, which makes it a potential target for ALS therapy. KIFAP3 has also been identified as the target of mir-130a.

Protocols

Product Specific Protocols
WB protocol for KIFAP3 antibody 60266-1-IgDownload protocol
IHC protocol for KIFAP3 antibody 60266-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...